• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Sitagliptin September 2010 Label Change

  • Janumet (sitagliptin and metformin HCl) fixed-dose combination tablets
  • Januvia (sitagliptin) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – September 2010

Summary View

 

ADVERSE REACTIONS

Postmarketing Experience
  • constipation
  • vomiting
  • headache